Market Cap 52.29B
Revenue (ttm) 9.26B
Net Income (ttm) 2.49B
EPS (ttm) N/A
PE Ratio 18.99
Forward PE 18.99
Profit Margin 26.86%
Debt to Equity Ratio 1.31
Volume 4,279,800
Avg Vol 4,107,028
Day's Range N/A - N/A
Shares Out 440.69M
Stochastic %K 2%
Beta 0.97
Analysts Strong Sell
Price Target $167.36

Company Profile

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermato...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 973 822 7000
Address:
10 Sylvan Way, Parsippany, United States
EWMInteractive
EWMInteractive Dec. 7 at 11:06 AM
$ZTS https://youtu.be/nt6BZF3Yg8Y #elliottwave
0 · Reply
EWMInteractive
EWMInteractive Dec. 7 at 10:34 AM
$ZTS https://ewminteractive.com/zoetis-50-decline-plants-seeds-recovery #elliottwave
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 1:40 AM
Actionable Trade Alert for $ZTS: Market Context: $ZTS is currently trading at $120.41, with an RSI of 48.54, indicating a neutral momentum. The stock is below its 30-day moving average (MA30) of 128.1 and 50-day moving average (MA50) of 134.53, suggesting potential bearish pressure. However, the price is above the 60-day low of 115.25, indicating some support. Directional Bias: The neutral RSI and proximity to the 60-day low suggest a potential rebound. If the stock breaks above the MA30, it could signal a bullish reversal. Trade Plan: - Suggested Entry: $121.00 - Stop Loss: $116.50 (3.7% below entry) - Take Profit Targets: 1. $126.00 (4.1% ROI) 2. $132.00 (9.1% ROI) 3. $141.00 (16.5% ROI) With a clear strategy, monitor the price action closely. If it breaks above the MA30, adjust the stop loss to lock in profits. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Dec. 5 at 7:09 PM
$ZTS new drug approval in Canada with solid fundamentals and that 119 area of congestion on the charts. Nibbling to start a position and may require a few in/outs until functionally moving off these levels.
0 · Reply
ZacksResearch
ZacksResearch Dec. 4 at 3:22 PM
Can $ZTS bounce back in 2026 after a rough year? Zoetis shares have slid 29.9% over the past year due to safety concerns with its OA therapies, Librela and Solensia, impacting sales and keeping the stock near its 52-week low. However, new approvals and robust growth in its parasiticides and dermatology portfolios might set the stage for a recovery next year. Discover the full outlook here 👉 https://www.zacks.com/stock/news/2799567/zoetis-stock-plummets-248-ytd-heres-what-you-need-to-know?cid=sm-stocktwits-2-2799567-body-23415&ADID=SYND_STOCKTWITS_TWEET_2_2799567_BODY_23415
0 · Reply
ZacksResearch
ZacksResearch Dec. 4 at 2:22 PM
$ZTS is getting crushed — is this the turning point? Safety concerns around its osteoarthritis therapies have slammed $ZTS with a 24.8% year-to-date drop, and the company’s now cutting revenue as it leans on new approvals to steady the ship. Full breakdown here 👉 https://www.zacks.com/stock/news/2799567/zoetis-stock-plummets-248-ytd-heres-what-you-need-to-know?cid=sm-stocktwits-2-2799567-teaser-23404&ADID=SYND_STOCKTWITS_TWEET_2_2799567_TEASER_23404
0 · Reply
GrowthWatcher
GrowthWatcher Dec. 3 at 12:15 PM
$ZTS Buffet fund may attract this valuation with dividends
0 · Reply
JarvisFlow
JarvisFlow Dec. 3 at 10:40 AM
BTIG updates rating for Zoetis ( $ZTS ) to Buy, target set at 160.
0 · Reply
LittleJohn213
LittleJohn213 Dec. 3 at 3:19 AM
$ZTS Came here to learn why the drop today and there are no posts today. Silent
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 1 at 3:46 PM
$ZTS Current Stock Price: $128.41 Contracts to trade: $130 ZTS Dec 19 2025 Call Entry: $2.55 Exit: $3.48 ROI: 36% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on ZTS
2 Stocks to Buy Near Their 52-Week Lows

Dec 1, 2025, 4:23 AM EST - 6 days ago

2 Stocks to Buy Near Their 52-Week Lows

PINS


Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst

Nov 21, 2025, 12:24 PM EST - 15 days ago

Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst


Zoetis to Host Innovation Webcast

Nov 19, 2025, 8:30 AM EST - 18 days ago

Zoetis to Host Innovation Webcast


2 Outstanding Dividend Stocks That Are Too Cheap to Ignore

Nov 15, 2025, 10:00 AM EST - 21 days ago

2 Outstanding Dividend Stocks That Are Too Cheap to Ignore

NOMD


Zoetis: A High-Quality Compounder Now On Sale?

Nov 14, 2025, 11:35 AM EST - 22 days ago

Zoetis: A High-Quality Compounder Now On Sale?


Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:16 PM EST - 4 weeks ago

Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript


Zoetis Stock Outlook Clouded By Rising Competitive Pressures

Nov 4, 2025, 1:15 PM EST - 4 weeks ago

Zoetis Stock Outlook Clouded By Rising Competitive Pressures


Zoetis: No Longer A Growth Stock

Nov 4, 2025, 12:41 PM EST - 4 weeks ago

Zoetis: No Longer A Growth Stock


Zoetis Announces Third Quarter 2025 Results

Nov 4, 2025, 7:00 AM EST - 4 weeks ago

Zoetis Announces Third Quarter 2025 Results


2 Magnificent Dividend Stocks to Buy and Hold Forever

Nov 2, 2025, 9:15 AM EST - 4 weeks ago

2 Magnificent Dividend Stocks to Buy and Hold Forever

ABBV


Buy Zoetis Stock Today?

Oct 31, 2025, 10:10 AM EDT - 5 weeks ago

Buy Zoetis Stock Today?


Zoetis Appoints Stephanie Tilenius to its Board of Directors

Oct 28, 2025, 8:30 AM EDT - 5 weeks ago

Zoetis Appoints Stephanie Tilenius to its Board of Directors


Zoetis Stock: Outlook Remains Muted

Oct 21, 2025, 6:48 AM EDT - 6 weeks ago

Zoetis Stock: Outlook Remains Muted


Zoetis Declares Fourth Quarter 2025 Dividend

Oct 9, 2025, 4:15 PM EDT - 2 months ago

Zoetis Declares Fourth Quarter 2025 Dividend


2 Magnificent Dividend Stocks to Buy Now and Hold Forever

Oct 8, 2025, 7:15 AM EDT - 2 months ago

2 Magnificent Dividend Stocks to Buy Now and Hold Forever

MA


Zoetis: A Solid Investment in the Growing Pet Medicine Market?

Oct 2, 2025, 7:00 PM EDT - 2 months ago

Zoetis: A Solid Investment in the Growing Pet Medicine Market?


Top 15 High-Growth Dividend Stocks For October 2025

Oct 1, 2025, 10:58 PM EDT - 2 months ago

Top 15 High-Growth Dividend Stocks For October 2025

ACN DPZ EOG FDX INTU MSCI NDSN


Pet Pain For Investor Gain

Sep 26, 2025, 10:19 AM EDT - 2 months ago

Pet Pain For Investor Gain


Zoetis: A Solid Dividend Growth Investment For The Long Haul

Sep 1, 2025, 4:14 AM EDT - 3 months ago

Zoetis: A Solid Dividend Growth Investment For The Long Haul


Zoetis: Why I Decided To Invest In The Stock

Aug 25, 2025, 1:45 AM EDT - 3 months ago

Zoetis: Why I Decided To Invest In The Stock


Got $1,000? 3 Dividend Stocks to Buy and Hold Forever

Aug 12, 2025, 5:52 AM EDT - 4 months ago

Got $1,000? 3 Dividend Stocks to Buy and Hold Forever

JNJ ZBH


Zoetis Announces Pricing of $1.85 Billion of Senior Notes

Aug 11, 2025, 6:48 PM EDT - 4 months ago

Zoetis Announces Pricing of $1.85 Billion of Senior Notes


2 Stocks to Buy With $5,000 and Hold for a Decade

Aug 10, 2025, 10:38 AM EDT - 4 months ago

2 Stocks to Buy With $5,000 and Hold for a Decade

RDDT


EWMInteractive
EWMInteractive Dec. 7 at 11:06 AM
$ZTS https://youtu.be/nt6BZF3Yg8Y #elliottwave
0 · Reply
EWMInteractive
EWMInteractive Dec. 7 at 10:34 AM
$ZTS https://ewminteractive.com/zoetis-50-decline-plants-seeds-recovery #elliottwave
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 1:40 AM
Actionable Trade Alert for $ZTS: Market Context: $ZTS is currently trading at $120.41, with an RSI of 48.54, indicating a neutral momentum. The stock is below its 30-day moving average (MA30) of 128.1 and 50-day moving average (MA50) of 134.53, suggesting potential bearish pressure. However, the price is above the 60-day low of 115.25, indicating some support. Directional Bias: The neutral RSI and proximity to the 60-day low suggest a potential rebound. If the stock breaks above the MA30, it could signal a bullish reversal. Trade Plan: - Suggested Entry: $121.00 - Stop Loss: $116.50 (3.7% below entry) - Take Profit Targets: 1. $126.00 (4.1% ROI) 2. $132.00 (9.1% ROI) 3. $141.00 (16.5% ROI) With a clear strategy, monitor the price action closely. If it breaks above the MA30, adjust the stop loss to lock in profits. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Dec. 5 at 7:09 PM
$ZTS new drug approval in Canada with solid fundamentals and that 119 area of congestion on the charts. Nibbling to start a position and may require a few in/outs until functionally moving off these levels.
0 · Reply
ZacksResearch
ZacksResearch Dec. 4 at 3:22 PM
Can $ZTS bounce back in 2026 after a rough year? Zoetis shares have slid 29.9% over the past year due to safety concerns with its OA therapies, Librela and Solensia, impacting sales and keeping the stock near its 52-week low. However, new approvals and robust growth in its parasiticides and dermatology portfolios might set the stage for a recovery next year. Discover the full outlook here 👉 https://www.zacks.com/stock/news/2799567/zoetis-stock-plummets-248-ytd-heres-what-you-need-to-know?cid=sm-stocktwits-2-2799567-body-23415&ADID=SYND_STOCKTWITS_TWEET_2_2799567_BODY_23415
0 · Reply
ZacksResearch
ZacksResearch Dec. 4 at 2:22 PM
$ZTS is getting crushed — is this the turning point? Safety concerns around its osteoarthritis therapies have slammed $ZTS with a 24.8% year-to-date drop, and the company’s now cutting revenue as it leans on new approvals to steady the ship. Full breakdown here 👉 https://www.zacks.com/stock/news/2799567/zoetis-stock-plummets-248-ytd-heres-what-you-need-to-know?cid=sm-stocktwits-2-2799567-teaser-23404&ADID=SYND_STOCKTWITS_TWEET_2_2799567_TEASER_23404
0 · Reply
GrowthWatcher
GrowthWatcher Dec. 3 at 12:15 PM
$ZTS Buffet fund may attract this valuation with dividends
0 · Reply
JarvisFlow
JarvisFlow Dec. 3 at 10:40 AM
BTIG updates rating for Zoetis ( $ZTS ) to Buy, target set at 160.
0 · Reply
LittleJohn213
LittleJohn213 Dec. 3 at 3:19 AM
$ZTS Came here to learn why the drop today and there are no posts today. Silent
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 1 at 3:46 PM
$ZTS Current Stock Price: $128.41 Contracts to trade: $130 ZTS Dec 19 2025 Call Entry: $2.55 Exit: $3.48 ROI: 36% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DividendPower
DividendPower Nov. 30 at 9:20 PM
The 2025 Dividend Contenders: A Complete List and Financial Insights - Updated 11/30/25 https://www.dividendpower.org/2025-dividend-contenders/ $ZTS $WM $WCN $A $BAC
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 28 at 9:18 AM
$ZTS Share Price: $127.66 Contract Selected: Apr 17, 2026 $130 Calls Buy Zone: $7.57 – $9.36 Target Zone: $14.08 – $17.21 Potential Upside: 76% ROI Time to Expiration: 139 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 26 at 11:10 PM
0 · Reply
MuneeMakr
MuneeMakr Nov. 26 at 10:38 PM
$ZTS not going to invest in this due to issues with their OA drugs for dogs and cats. Speaking from personal experience. It’s not about the money just can’t support those products.
1 · Reply
PineappleInvesting
PineappleInvesting Nov. 26 at 9:23 PM
0 · Reply
wisdon
wisdon Nov. 26 at 7:57 PM
$ZTS VETERINARY TRENDING $IVP
0 · Reply
hitmongreen
hitmongreen Nov. 25 at 9:52 PM
$ZTS someone or group is buying the ish outta this name. What is retail missing?
1 · Reply
OptionRunners
OptionRunners Nov. 25 at 6:15 PM
$ZTS calls up to $1.60 now
0 · Reply
Peaceouty
Peaceouty Nov. 25 at 5:49 PM
0 · Reply
OptionRunners
OptionRunners Nov. 25 at 4:22 PM
$ZTS Buyer of the December 19th $135 calls 5,000 times for $0.95-$1.00
0 · Reply
Kevbot29
Kevbot29 Nov. 25 at 3:53 PM
$ZTS that buy at $116 was so solid. The deep ITM 2028 calls that were bought was the big give away. Soon enough a whale will announce a position. Wouldn’t surprise me if it was Buffett
1 · Reply
SuperGreenToday
SuperGreenToday Nov. 25 at 2:34 AM
$ZTS Share Price: $122.88 Contract Selected: Apr 17, 2026 $125 Calls Buy Zone: $5.87 – $7.25 Target Zone: $10.26 – $12.54 Potential Upside: 65% ROI Time to Expiration: 143 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply